At CellCarta, we’re dedicated to working with our partners to further the limitless potential of precision medicine. As a global contract research organization (CRO), our broad technology offering is designed to address specific therapeutic development requirements, and provide the most highly customized solutions – ones that set our partners up for success at every stage. As a leading provider of specialized precision medicine laboratory services with integrated platforms in immunology, histopathology, proteomics, genomics, and related specimen collection and logistics services. CellCarta supports the entire drug development cycle, from discovery to late-stage clinical trials, and operates globally with laboratories in Canada, USA, Belgium, Australia, and China.
CellCarta
Related Resources
dPCR Case Study
Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring your adoptive cell therapy (ACT) meets safety regulations relating to VCN and RCL/RCR levels, even...
Partner with Experts in Precision Medicine
At CellCarta, we’re dedicated to working with our partners to further the limitless potential of precision medicine. Our broad technology offering is designed to address specific therapeutic development requirements and provide the most highly customized...